Conservest Capital Advisors Inc. Has $429,000 Stake in Lam Research Co. (NASDAQ:LRCX)

Conservest Capital Advisors Inc. trimmed its stake in Lam Research Co. (NASDAQ:LRCX) by 4.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 548 shares of the semiconductor company’s stock after selling 26 shares during the period. Conservest Capital Advisors Inc.’s holdings in Lam Research were worth $429,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. PGGM Investments grew its holdings in Lam Research by 0.7% during the 4th quarter. PGGM Investments now owns 14,781 shares of the semiconductor company’s stock worth $11,577,000 after acquiring an additional 104 shares during the period. Transcend Capital Advisors LLC bought a new position in shares of Lam Research during the 4th quarter worth about $710,000. Unique Wealth Strategies LLC bought a new position in shares of Lam Research during the 4th quarter worth about $759,000. Dohj LLC bought a new position in Lam Research in the 4th quarter valued at about $500,000. Finally, Gilliland Jeter Wealth Management LLC bought a new position in Lam Research in the 4th quarter valued at about $2,017,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on LRCX shares. Susquehanna decreased their price objective on shares of Lam Research from $880.00 to $850.00 and set a “neutral” rating for the company in a research note on Thursday. Citigroup upped their price target on shares of Lam Research from $975.00 to $1,025.00 and gave the company a “buy” rating in a research report on Thursday. StockNews.com upgraded shares of Lam Research from a “hold” rating to a “buy” rating in a research report on Friday. JPMorgan Chase & Co. upped their price objective on shares of Lam Research from $900.00 to $950.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, The Goldman Sachs Group upped their price objective on shares of Lam Research from $700.00 to $912.00 and gave the company a “buy” rating in a research note on Thursday, January 25th. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $950.85.

Lam Research Stock Performance

Shares of Lam Research stock traded up $23.90 on Friday, hitting $925.37. 1,397,129 shares of the company’s stock were exchanged, compared to its average volume of 1,010,097. The company has a 50-day simple moving average of $943.67 and a 200-day simple moving average of $810.33. The stock has a market capitalization of $121.32 billion, a PE ratio of 34.03, a PEG ratio of 3.29 and a beta of 1.51. Lam Research Co. has a 1 year low of $493.42 and a 1 year high of $1,007.39. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.02 and a current ratio of 2.82.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.26 by $0.53. The business had revenue of $3.79 billion for the quarter, compared to analysts’ expectations of $3.72 billion. Lam Research had a net margin of 25.35% and a return on equity of 45.96%. The company’s revenue was down 2.0% compared to the same quarter last year. During the same quarter last year, the company posted $6.99 EPS. As a group, equities analysts anticipate that Lam Research Co. will post 29.54 EPS for the current year.

Lam Research Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 3rd. Investors of record on Wednesday, March 13th were paid a dividend of $2.00 per share. The ex-dividend date of this dividend was Tuesday, March 12th. This represents a $8.00 dividend on an annualized basis and a dividend yield of 0.86%. Lam Research’s dividend payout ratio is presently 29.42%.

Insider Buying and Selling

In other news, Director Abhijit Y. Talwalkar sold 882 shares of the business’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $972.03, for a total value of $857,330.46. Following the completion of the sale, the director now owns 10,541 shares in the company, valued at approximately $10,246,168.23. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the transaction, the director now owns 10,541 shares in the company, valued at approximately $10,246,168.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Christina Corrreia sold 647 shares of the company’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $628,903.41. Following the completion of the sale, the chief accounting officer now directly owns 5,541 shares in the company, valued at $5,386,018.23. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,029 shares of company stock valued at $6,559,489. Company insiders own 0.32% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.